Nephrogen
Genomics & Genetic Testing · Health Care
Overview
Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases.
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Nephrogen, Inc., New York, NY
Other sponsors in the same field
Admera Health 4 filings
Integrated DNA Technologies 3 filings
NeoGenomics Laboratories 3 filings
Myriad Genetics 2 filings
Alert me
US Department of Labor · latest filing May 2, 2025 · Visa details by country
Financials
Total raised
$325k
Latest round
Grant
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2023 | $325k | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
TechstarsVia a fund
4363 portfolio companies
Y CombinatorVia a fund
6311 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids
AAV vectors show promise for gene therapy; however, kidney gene transfer remains challenging. Here we conduct a barcode-seq-based comparison of 47 AAV capsids administered through different routes in mice, followed by individual validation. We find that l
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ